Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer
Peeters, M., Price, T.J., Cervantes, A., Sobrero, A.F., Ducreux, M., Hotko, Y., André, T., Chan, E., Lordick, F., Punt, C.J.A., Strickland, A.H., Wilson, G., Ciuleanu, T.E., Roman, L., Van Cutsem, E., Tian, Y., Sidhu, R.
Published in Annals of oncology (01.01.2014)
Published in Annals of oncology (01.01.2014)
Get full text
Journal Article
Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy
Campone, M., Bondarenko, I., Brincat, S., Hotko, Y., Munster, P.N., Chmielowska, E., Fumoleau, P., Ward, R., Bardy-Bouxin, N., Leip, E., Turnbull, K., Zacharchuk, C., Epstein, R.J.
Published in Annals of oncology (01.03.2012)
Published in Annals of oncology (01.03.2012)
Get full text
Journal Article
1609 Final results from PAVES, a phase 3, randomized, double-blind, placebo-controlled trial of pegfilgrastim in patients (pts) receiving first-line FOLFOX or FOLFIRI and bevacizumab for locally advanced or metastatic colorectal cancer (LA/mCRC) (NCT00911170)
Pinter, T, Morrow, P.K, Cesas, A, Croitoru, A, Decaestecker, J, Gibbs, P, Hotko, Y, Jassem, J, Kurteva, G, Novotny, J, O'Reilly, S, Salek, T, Khosrowshahi, L, Reiner, M, Klippel, Z, Blanke, C
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
14LBA Randomized phase 3 study of panitumumab with FOLFIRI vs FOLFIRI alone as second-line treatment (tx) in patients (pts) with metastatic colorectal cancer (mCRC)
Peeters, M, Price, T, Hotko, Y, Cervantes, A, Ducreux, M, André, T, Chan, E, Lordick, F, Rong, A, Gansert, J
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
KRAS/NRAS and BRAF Mutations in the 20050181 Study of Panitumumab + FOLFIRI for the 2ND-Line Treatment of Metastatic Colorectal Cancer: Updated Analysis
Peeters, M., Oliner, K., Price, T., Cervantes, A., Sobrero, A., Ducreux, M., Hotko, Y., André, T., Chan, E., Lordick, F., Punt, C., Strickland, A., Wilson, G., Ciuleanu, T., Roman, L., Van Cutsem, E., Yu, H., Jung, A.S., Sidhu, R., Patterson, S.
Published in Annals of oncology (01.06.2014)
Published in Annals of oncology (01.06.2014)
Get full text
Journal Article
Molecular and clinical predictors of outcome for cetuximab in non-small cell lung cancer (NSCLC): Data from the FLEX study
O'Byrne, K. J., Bondarenko, I., Barrios, C., Eschbach, C., Martens, U., Hotko, Y., Kortsik, C., Celik, I., Stroh, C., Pirker, R.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Phase III study (20050181) of panitumumab (pmab) with FOLFIRI versus FOLFIRI alone as second-line treatment (tx) in patients (pts) with metastatic colorectal cancer (mCRC): Pooled safety results
Peeters, M., Wilson, G., Ducreux, M., Cervantes, A., André, T., Hotko, Y., Lordick, F., Collins, S., Shing, M., Price, T. J.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
A phase II study of ARQ 501 in patients with advanced squamous cell carcinoma of the head and neck
Kawecki, A., Adkins, D. R., Cunningham, C. C., Vokes, E., Yagovane, D. M., Dombal, G., Koralewski, P., Hotko, Y., Vladimirov, V.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Randomized Phase 3 Study of Panitumumab With FOLFIRI vs. FOLFIRI Alone as Second-Line Treatment in Patients With Metastatic Colorectal Cancer
Ducreux, M., Price, T., Hotko, Y., Cervantes, A., André, T., Chan, E., Lordick, F., Rong, A., Gansert, J., Peeters, M.
Published in Gastrointestinal cancer research (01.01.2010)
Get full text
Published in Gastrointestinal cancer research (01.01.2010)
Journal Article
Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy
Campone, M, Bondarenko, I, Brincat, S, Hotko, Y, Munster, P N, Chmielowska, E, Fumoleau, P, Ward, R, Bardy-Bouxin, N, Leip, E, Turnbull, K, Zacharchuk, C, Epstein, R J
Published in Annals of oncology (01.03.2012)
Get full text
Published in Annals of oncology (01.03.2012)
Journal Article
CO.76 Etude de phase III (20050181) de l’association panitumumab + 5-fluorouracile, acide folinique, irinotecan (Folfiri) versus Folfiri seul en seconde ligne de traitement des cancers colorectaux métastasés. Analyse poolée de toxicité
Ducreux, M., Wilson, G., Cervantès, A., André, T., Hotko, Y., Lordick, F., Collins, S., Shing, M., Price, T., Peeters, M.
Published in Gastroentérologie clinique et biologique (01.03.2009)
Published in Gastroentérologie clinique et biologique (01.03.2009)
Get full text
Journal Article